Skip to main content
SpringerLink
Log in
Book cover

Integrin and Cell Adhesion Molecules pp 471–486Cite as

Integrins in Tumor Angiogenesis and Lymphangiogenesis

  • Protocol
  • First Online:

Part of the book series: Methods in Molecular Biology ((MIMB,volume 757))

Abstract

Angiogenesis, the formation of new blood vessel, plays an important role for the growth and metastasis of malignant tumors. The recent identification of specific growth factors for lymphatic vessels and of new lymphatic-specific markers provided evidence for an active role of the lymphatic system during the tumor growth and metastasis processes. Tumor lymphangiogenesis has been shown to play a role in promoting tumor growth and metastasis of tumor cells to distant sites. Integrins play keys roles in the regulation of angiogenesis and lymphangiogenesis during normal development and several diseases. Indeed, integrins control vascular and lymphatic endothelial cell adhesion, migration, and survival. Importantly, integrin inhibitors can block angiogenesis and lymphangiogenesis. In this chapter, we will highlight the role of integrins during angiogenesis and lymphangiogenesis as well as the function of individual integrins during vascular development, postnatal angiogenesis, and lymphangiogenesis. We discuss the role of integrins as potential therapeutic targets for the control of tumor angiogenesis, lymphangiogenesis, and metastatic spread in the treatment of cancer. We also describe methods to analyze expression and function of integrins during angiogenesis and lymphangiogenesis.

This is a preview of subscription content, log in via an institution.

Protocol
USD   49.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Springer Nature is developing a new tool to find and evaluate Protocols. Learn more

References

  1. Carmeliet, P. (2005) Angiogenesis in life, disease and medicine. Nature 438, 932–936.

    Article  PubMed  CAS  Google Scholar 

  2. Conway, E. M., Collen, D., and Carmeliet, P. (2001) Molecular mechanisms of blood vessel growth. Cardiovasc. Res. 49, 507–521.

    Article  PubMed  CAS  Google Scholar 

  3. Alitalo, K., Tammela, T., and Petrova, T. V. (2005) Lymphangiogenesis in development and human disease. Nature 438, 946–953.

    Article  PubMed  CAS  Google Scholar 

  4. Mandriota, S. J., Jussila, L., Jeltsch, M., Compagni, A., Baetens, D., Prevo, R., Banerji, S., Huarte, J., Montesano, R., Jackson, D. G., Orci, L., Alitalo, K., Christofori, G., and Pepper, M. S. (2001) Vascular endothelial growth factor-C-mediated lymphangiogenesis promotes tumour metastasis. EMBO J. 20, 672–682.

    Article  PubMed  CAS  Google Scholar 

  5. He, Y., Kozaki, K., Karpanen, T., Koshikawa, K., Yla-Herttuala, S., Takahashi, T., and Alitalo, K. (2002) Suppression of tumor lymphangiogenesis and lymph node metastasis by blocking vascular endothelial growth factor receptor 3 signaling. J. Natl. Cancer Inst. 94, 819–825.

    Article  PubMed  CAS  Google Scholar 

  6. Okazaki, T., Ni, A., Ayeni, O. A., Baluk, P., Yao, L. C., Vossmeyer, D., Zischinsky, G., Zahn, G., Knolle, J., Christner, C., and McDonald, D. M. (2009) alpha5beta1 Integrin blockade inhibits lymphangiogenesis in airway inflammation. Am. J. Pathol. 174,2378–2387.

    Article  PubMed  CAS  Google Scholar 

  7. Hynes, R. O. (2002) Integrins: bidirectional, allosteric signaling machines. Cell 110, 673–687.

    Article  PubMed  CAS  Google Scholar 

  8. Cheresh, D. A., and Stupack, D. G. (2008) Regulation of angiogenesis: apoptotic cues from the ECM. Oncogene 27, 6285–6298.

    Article  PubMed  CAS  Google Scholar 

  9. Hynes, R. O. (2002) A reevaluation of integrins as regulators of angiogenesis. Nat. Med. 8, 918–921.

    Article  PubMed  CAS  Google Scholar 

  10. Serini, G., Valdembri, D., and Bussolino, F. (2006) Integrins and angiogenesis: a sticky business. Exp. Cell Res. 312, 651–658.

    Article  PubMed  CAS  Google Scholar 

  11. Sund, M., Hamano, Y., Sugimoto, H., Sudhakar, A., Soubasakos, M., Yerramalla, U., Benjamin, L. E., Lawler, J., Kieran, M., Shah, A., and Kalluri, R. (2005) Function of endogenous inhibitors of angiogenesis as endothelium-specific tumor suppressors. Proc. Natl. Acad. Sci. USA. 102, 2934–2939.

    Article  PubMed  CAS  Google Scholar 

  12. Senger, D. R., Claffey, K. P., Benes, J. E., Perruzzi, C. A., Sergiou, A. P., and Detmar, M. (1997) Angiogenesis promoted by vascular endothelial growth factor: regulation through alpha1beta1 and alpha2beta1 integrins. Proc. Natl. Acad. Sci. USA. 94, 13612–13617.

    Article  PubMed  CAS  Google Scholar 

  13. Pozzi, A., Moberg, P. E., Miles, L. A., Wagner, S., Soloway, P., and Gardner, H. A. (2000) Elevated matrix metalloprotease and angiostatin levels in integrin alpha 1 knockout mice cause reduced tumor vascularization. Proc. Natl. Acad. Sci. USA. 97, 2202–2207.

    Article  PubMed  CAS  Google Scholar 

  14. Friedlander, M., Brooks, P. C., Shaffer, R. W., Kincaid, C. M., Varner, J. A., and Cheresh, D. A. (1995) Definition of two angiogenic pathways by distinct alpha v integrins. Science 270, 1500–1502.

    Article  PubMed  CAS  Google Scholar 

  15. Reynolds, L. E., Wyder, L., Lively, J. C., Taverna, D., Robinson, S. D., Huang, X., Sheppard, D., Hynes, R. O., and Hodivala-Dilke, K. M. (2002) Enhanced pathological angiogenesis in mice lacking beta3 integrin or beta3 and beta5 integrins. Nat. Med. 8, 27–34.

    Article  PubMed  CAS  Google Scholar 

  16. Brooks, P. C., Montgomery, A. M., Rosenfeld, M., Reisfeld, R. A., Hu, T., Klier, G., and Cheresh, D. A. (1994) Integrin alpha v beta 3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels. Cell 79, 1157–1164.

    Article  PubMed  CAS  Google Scholar 

  17. Stupack, D. G., Puente, X. S., Boutsaboualoy, S., Storgard, C. M., and Cheresh, D. A. (2001) Apoptosis of adherent cells by recruitment of caspase-8 to unligated integrins. J. Cell Biol. 155, 459–470.

    Article  PubMed  CAS  Google Scholar 

  18. Reynolds, A. R., Reynolds, L. E., Nagel, T. E., Lively, J. C., Robinson, S. D., Hicklin, D. J., Bodary, S. C., and Hodivala-Dilke, K. M. (2004) Elevated Flk1 (vascular endothelial growth factor receptor 2) signaling ­mediates enhanced angiogenesis in beta3-integrin-deficient mice. Cancer Res. 64, 8643–8650.

    Article  PubMed  CAS  Google Scholar 

  19. Mahabeleshwar, G. H., Feng, W., Phillips, D. R., and Byzova, T. V. (2006) Integrin signaling is critical for pathological angiogenesis. J. Exp Med. 203, 2495–2507.

    Article  PubMed  CAS  Google Scholar 

  20. van Hinsbergh, V. W., Engelse, M. A., and Quax, P. H. (2006) Pericellular proteases in angiogenesis and vasculogenesis. Arterioscler Thromb. Vasc. Biol. 26, 716–728.

    Article  PubMed  Google Scholar 

  21. Nikolopoulos, S. N., Blaikie, P., Yoshioka, T., Guo, W., and Giancotti, F. G. (2004) Integrin beta4 signaling promotes tumor angiogenesis. Cancer Cell 6, 471–483.

    Article  PubMed  CAS  Google Scholar 

  22. Silva, R., D’Amico, G., Hodivala-Dilke, K. M., and Reynolds, L. E. (2008) Integrins: the keys to unlocking angiogenesis. Arterioscler. Thromb. Vasc. Biol. 28, 1703–1713.

    Article  PubMed  CAS  Google Scholar 

  23. Huang, X. Z., Wu, J. F., Ferrando, R., Lee, J. H., Wang, Y. L., Farese, R. V., Jr., and Sheppard, D. (2000) Fatal bilateral chylothorax in mice lacking the integrin alpha9beta1. Mol. Cell. Biol. 20, 5208–5215.

    Article  PubMed  CAS  Google Scholar 

  24. Mishima, K., Watabe, T., Saito, A., Yoshimatsu, Y., Imaizumi, N., Masui, S., Hirashima, M., Morisada, T., Oike, Y., Araie, M., Niwa, H., Kubo, H., Suda, T., and Miyazono, K. (2007) Prox1 induces lymphatic endothelial differentiation via integrin alpha9 and other signaling cascades. Mol. Biol. Cell 18, 1421–1429.

    Article  PubMed  CAS  Google Scholar 

  25. Vlahakis, N. E., Young, B. A., Atakilit, A., Hawkridge, A. E., Issaka, R. B., Boudreau, N., and Sheppard, D. (2007) Integrin alpha9beta1 directly binds to vascular endothelial growth factor (VEGF)-A and contributes to VEGF-A-induced angiogenesis. J. Biol. Chem. 282, 15187–15196.

    Article  PubMed  CAS  Google Scholar 

  26. Hong, Y. K., Lange-Asschenfeldt, B., Velasco, P., Hirakawa, S., Kunstfeld, R., Brown, L. F., Bohlen, P., Senger, D. R., and Detmar, M. (2004) VEGF-A promotes tissue repair-associated lymphatic vessel formation via VEGFR-2 and the alpha1beta1 and alpha2beta1 integrins. FASEB J. 18, 1111–1113.

    PubMed  CAS  Google Scholar 

  27. Norgall, S., Papoutsi, M., Rossler, J., Schweigerer, L., Wilting, J., and Weich, H. A. (2007) Elevated expression of VEGFR-3 in lymphatic endothelial cells from lymphangiomas. BMC Cancer 7, 105.

    Article  PubMed  Google Scholar 

  28. Zhang, X., Groopman, J. E., and Wang, J. F. (2005) Extracellular matrix regulates endothelial functions through interaction of VEGFR-3 and integrin alpha5beta1. J. Cell Physiol. 202, 205–214.

    Article  PubMed  CAS  Google Scholar 

  29. Dietrich, T., Onderka, J., Bock, F., Kruse, F. E., Vossmeyer, D., Stragies, R., Zahn, G., and Cursiefen, C. (2007) Inhibition of inflammatory lymphangiogenesis by integrin alpha5 blockade. Am. J. Pathol. 171, 361–372.

    Article  PubMed  CAS  Google Scholar 

  30. Sudhakar, A., Sugimoto, H., Yang, C., Lively, J., Zeisberg, M., and Kalluri, R. (2003) Human tumstatin and human endostatin exhibit distinct antiangiogenic activities mediated by alpha v beta 3 and alpha 5 beta 1 integrins. Proc. Natl. Acad. Sci. USA. 100, 4766–4771.

    Article  PubMed  CAS  Google Scholar 

  31. Brideau, G., Makinen, M. J., Elamaa, H., Tu, H., Nilsson, G., Alitalo, K., Pihlajaniemi, T., and Heljasvaara, R. (2007) Endostatin overexpression inhibits lymphangiogenesis and lymph node metastasis in mice. Cancer Res. 67, 11528–11535.

    Article  PubMed  CAS  Google Scholar 

  32. Garmy-Susini, B., Makale, M., Fuster, M., and Varner, J. A. (2007) Methods to study lymphatic vessel integrins. Methods Enzymol 426, 415–438.

    Article  PubMed  CAS  Google Scholar 

  33. Friedlander, M., Theesfeld, C. L., Sugita, M., Fruttiger, M., Thomas, M. A., Chang, S., and Cheresh, D. A. (1996) Involvement of integrins alpha v beta 3 and alpha v beta 5 in ocular neovascular diseases. Proc. Natl. Acad. Sci. USA. 93, 9764–9769.

    Article  PubMed  CAS  Google Scholar 

  34. Zhang, D., Pier, T., McNeel, D. G., Wilding, G., and Friedl, A. (2007) Effects of a monoclonal anti-alphavbeta3 integrin antibody on blood vessels – a pharmacodynamic study. Invest. New Drugs 25, 49–55.

    Article  PubMed  CAS  Google Scholar 

  35. Trikha, M., Zhou, Z., Nemeth, J. A., Chen, Q., Sharp, C., Emmell, E., Giles-Komar, J., and Nakada, M. T. (2004) CNTO 95, a fully human monoclonal antibody that inhibits alphav integrins, has antitumor and antiangiogenic activity in vivo. Int. J. Cancer 110, 326–335.

    Article  PubMed  CAS  Google Scholar 

  36. Mullamitha, S. A., Ton, N. C., Parker, G. J., Jackson, A., Julyan, P. J., Roberts, C., Buonaccorsi, G. A., Watson, Y., Davies, K., Cheung, S., Hope, L., Valle, J. W., Radford, J. A., Lawrance, J., Saunders, M. P., Munteanu, M. C., Nakada, M. T., Nemeth, J. A., Davis, H. M., Jiao, Q., Prabhakar, U., Lang, Z., Corringham, R. E., Beckman, R. A., and Jayson, G. C. (2007) Phase I evaluation of a fully human anti-alphav integrin monoclonal antibody (CNTO 95) in patients with advanced solid tumors. Clin. Cancer Res. 13, 2128–2135.

    Article  PubMed  CAS  Google Scholar 

  37. Brooks, P. C., Klemke, R. L., Schon, S., Lewis, J. M., Schwartz, M. A., and Cheresh, D. A. (1997) Insulin-like growth factor receptor cooperates with integrin alpha v beta 5 to promote tumor cell dissemination in vivo. J. Clin. Invest. 99, 1390–1398.

    Article  PubMed  CAS  Google Scholar 

  38. Stupp, R., and Ruegg, C. (2007) Integrin inhibitors reaching the clinic. J. Clin. Oncol. 25, 1637–1638.

    Article  PubMed  CAS  Google Scholar 

  39. Hariharan, S., Gustafson, D., Holden, S., McConkey, D., Davis, D., Morrow, M., Basche, M., Gore, L., Zang, C., O’Bryant, C. L., Baron, A., Gallemann, D., Colevas, D., and Eckhardt, S. G. (2007) Assessment of the biological and pharmacological effects of the alpha nu beta3 and alpha nu beta5 integrin receptor antagonist, cilengitide (EMD 121974), in patients with advanced solid tumors. Ann. Oncol. 18, 1400–1407.

    Article  PubMed  CAS  Google Scholar 

  40. Friess, H., Langrehr, J. M., Oettle, H., Raedle, J., Niedergethmann, M., Dittrich, C., Hossfeld, D. K., Stoger, H., Neyns, B., Herzog, P., Piedbois, P., Dobrowolski, F., Scheithauer, W., Hawkins, R., Katz, F., Balcke, P., Vermorken, J., van Belle, S., Davidson, N., Esteve, A. A., Castellano, D., Kleeff, J., Tempia-Caliera, A. A., Kovar, A., and Nippgen, J. (2006) A randomized multi-center phase II trial of the angiogenesis inhibitor Cilengitide (EMD 121974) and gemcitabine compared with gemcitabine alone in advanced unresectable pancreatic cancer. BMC Cancer 6, 285.

    Article  PubMed  Google Scholar 

  41. Ramakrishnan, V., Bhaskar, V., Law, D. A., Wong, M. H., DuBridge, R. B., Breinberg, D., O’Hara, C., Powers, D. B., Liu, G., Grove, J., Hevezi, P., Cass, K. M., Watson, S., Evangelista, F., Powers, R. A., Finck, B., Wills, M., Caras, I., Fang, Y., McDonald, D., Johnson, D., Murray, R., and Jeffry, U. (2006) Preclinical evaluation of an anti-alpha5beta1 integrin antibody as a novel anti-angiogenic agent. J. Exp. Ther. Oncol. 5, 273–286.

    PubMed  CAS  Google Scholar 

  42. Kuwada, S. K. (2007) Drug evaluation: Volociximab, an angiogenesis-inhibiting chimeric monoclonal antibody. Curr. Opin. Mol. Ther. 9, 92–98.

    PubMed  CAS  Google Scholar 

  43. Ma, W. W., and Adjei, A. A. (2009) Novel agents on the horizon for cancer therapy. CA Cancer J. Clin. 59, 111–137.

    Article  PubMed  Google Scholar 

  44. Stoeltzing, O., Liu, W., Reinmuth, N., Fan, F., Parry, G. C., Parikh, A. A., McCarty, M. F., Bucana, C. D., Mazar, A. P., and Ellis, L. M. (2003) Inhibition of integrin alpha5beta1 function with a small peptide (ATN-161) plus continuous 5-FU infusion reduces colorectal liver metastases and improves survival in mice. Int. J. Cancer. 104, 496–503.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Moores UCSD Cancer Center, University of California, San Diego, La Jolla, CA, USA

    Philippe Foubert & Judith A. Varner

Authors
  1. Philippe Foubert
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Judith A. Varner
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Judith A. Varner .

Editor information

Editors and Affiliations

  1. Immune Disease Institute, Harvard Medical School, Longwood Avenue 200, Boston, 02115, Massachusetts, USA

    Motomu Shimaoka

Rights and permissions

Reprints and permissions

Copyright information

© 2011 Springer Science+Business Media, LLC

About this protocol

Cite this protocol

Foubert, P., Varner, J.A. (2011). Integrins in Tumor Angiogenesis and Lymphangiogenesis. In: Shimaoka, M. (eds) Integrin and Cell Adhesion Molecules. Methods in Molecular Biology, vol 757. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-61779-166-6_27

Download citation

  • DOI: https://doi.org/10.1007/978-1-61779-166-6_27

  • Published:

  • Publisher Name: Humana Press, Totowa, NJ

  • Print ISBN: 978-1-61779-165-9

  • Online ISBN: 978-1-61779-166-6

  • eBook Packages: Springer Protocols

Publish with us

Policies and ethics

Search

Navigation